Claims
- 1. A compound selected from the group consisting of an optionally active compound of the formula: ##STR38## and a racemic compound of that formula and the mirror image thereof wherein m is an integer from 2 to 5, inclusive, and n is an integer from 3 to 6, inclusive, R is selected from the group consisting of hydrogen and C.sub.1 -C.sub.4 alkyl; and the pharmacologically acceptable cationic salts thereof.
- 2. A compound according to claim 1, wherein n and m are as previously defined; and R is hydrogen.
- 3. A compound according to claim 1, wherein n and m are as previously defined; and R is selected from the group consisting of C.sub.1 -C.sub.4 alkyl.
- 4. A compound according to claim 2, wherein n and R as previously defined; and m is the integer 3.
- 5. A compound according to claim 3, wherein m and R are as previously defined; and m is the integer 3.
- 6. The enantiomer according to claim 1, l-9-oxo-11.alpha.,15-dihydroxy-5-cis,13-cis-prostadienoic acid.
- 7. The racemate according to claim 1, dl-9-oxo-11.alpha.,15-dihydroxy-5-cis,13-cis-prostadienoic acid.
- 8. The enantiomer according to claim 1, l-9-oxo-11.alpha.,15-dihdyroxy-4,20-bisnor-5-cis,13-cis-prostadienoic acid.
- 9. The racemate according to claim 1, dl-9-oxo-11.alpha.,15-dihdroxy-4,20-bisnor-5-cis,13-cis-prostadienoic acid.
Parent Case Info
This application is a continuation-in-part of my copending application Ser. No. 521,719, filed Nov. 7, 1974, now abandoned, which is in turn a continuation of application Ser. No. 355,352, filed Apr. 27, 1973, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3932479 |
Bernady et al. |
Jan 1976 |
|
4026909 |
Yankee |
May 1977 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
355352 |
Apr 1973 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
521719 |
Nov 1974 |
|